CMC Corporation (TYO:2185)

Market Cap	20.33B
Revenue (ttm)	18.82B
Net Income (ttm)	2.10B
Shares Out	13.03M
EPS (ttm)	158.91
PE Ratio	9.82
Forward PE	n/a
Dividend	56.00 (3.66%)
Ex-Dividend Date	Sep 29, 2025

Volume	2,600
Average Volume	6,375
Open	1,578.00
Previous Close	1,594.00
Day's Range	1,541.00 - 1,581.00
52-Week Range	1,040.00 - 1,847.00
Beta	0.35
RSI	70.98
Earnings Date	Aug 8, 2025

About Revance Therapeutics

CMC Corporation, together with its subsidiaries, provides manual creation, business process management, training, translation, and interpretation services in Japan. The company provides technical information, such as user manuals, AR manuals, data structuring, and XML editor; personnel development solutions, including training events, staff manuals, training programs, and virtual work experiences; process improvement solutions, such as knowledge transfer and management, process improvement, document management, and RPA applications; and marketi...

• Industry: Information Technology Services
• Sector: Technology
• Founded: 1962
• Employees: 862
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2185

Financial Performance

In 2024, CMC Corporation's revenue was 19.52 billion, an increase of 5.81% compared to the previous year's 18.45 billion. Earnings were 2.08 billion, an increase of 17.93%.